Evidence map›Paper›PMID 31026769›Full record

ArticleRedox biology2019

Hyperhomocysteinemia-induced death of retinal ganglion cells: The role of Müller glial cells and NRF2.

Soumya Navneet, Jing Zhao, Jing Wang, Barbara Mysona, Shannon Barwick, Navneet Ammal Kaidery, Alan Saul, Ismail Kaddour-Djebbar, Wendy B Bollag, Bobby Thomas and 2 more

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Homocysteine and Glaucoma.International journal of molecular sciences · 2023
    Review
  17. Review
  18. Article
  19. Article
  20. Controlling the Impact ofMedicina (Kaunas, Lithuania) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Soumya NavneetDepartment of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA; James and Jean Culver Vision Discovery Institute, Augusta University, Augusta, GA, USA.
Jing ZhaoJames and Jean Culver Vision Discovery Institute, Augusta University, Augusta, GA, USA; Department of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Jing WangDepartment of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA; James and Jean Culver Vision Discovery Institute, Augusta University, Augusta, GA, USA.
Barbara MysonaDepartment of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA; James and Jean Culver Vision Discovery Institute, Augusta University, Augusta, GA, USA; Department of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Shannon BarwickDepartment of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA; James and Jean Culver Vision Discovery Institute, Augusta University, Augusta, GA, USA.
Navneet Ammal KaideryDepartment of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA, USA; Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA.
Alan SaulJames and Jean Culver Vision Discovery Institute, Augusta University, Augusta, GA, USA; Department of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Ismail Kaddour-DjebbarDepartment of Physiology, Medical College of Georgia, Augusta University, Augusta, GA, USA; Charlie Norwood VA Medical Center, One Freedom Way, Augusta, GA, 30904, USA.
Wendy B BollagDepartment of Physiology, Medical College of Georgia, Augusta University, Augusta, GA, USA; Charlie Norwood VA Medical Center, One Freedom Way, Augusta, GA, 30904, USA.
Bobby ThomasDepartment of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, GA, USA; Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA; Department of Neuroscience, Medical University of South Carolina, Charleston, SC, USA; Department of Drug Discovery, Medical University of South Carolina, Charleston, SC, USA.
Kathryn E BollingerDepartment of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA; James and Jean Culver Vision Discovery Institute, Augusta University, Augusta, GA, USA; Department of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Sylvia B SmithDepartment of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA; James and Jean Culver Vision Discovery Institute, Augusta University, Augusta, GA, USA; Department of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA, USA. Electronic address: sbsmith@augusta.edu.
Augusta University · USDiscovery Institute · USCharlie Norwood VA Medical Center · USMedical University of South Carolina · US

Funding

Role of homocysteine in retinal diseaseR01EY012830 · NEI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI SMITH, SYLVIA B. · 2000 to 2016
$4.4M
The Mechanism of Sigma 1 Receptor Mediated Neuroprotection in GlaucomaR01EY027406 · NEI · AUGUSTA UNIVERSITY · PI Kathryn Bollinger · 2018 to 2026
$3.2M
Role of Bach-1-Mediated Transcriptional Regulation in NeuroprotectionR01NS101967 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI THOMAS, BOBBY · 2017 to 2021
$1.9M
Sigma 1 Receptor: a novel therapeutic target for retinal degenerationR01EY028103 · NEI · AUGUSTA UNIVERSITY · PI SMITH, SYLVIA B. · 2017 to 2019
$1.2M
NEI NIH HHS R01 EY012830NEI NIH HHS R01 EY027406NEI NIH HHS R01 EY028103NINDS NIH HHS R01 NS101967
6 · The paper itself

Abstract

Hyperhomocysteinemia (Hhcy), or increased levels of the excitatory amino acid homocysteine (Hcy), is implicated in glaucoma, a disease characterized by increased oxidative stress and loss of retinal ganglion cells (RGCs). Whether Hhcy is causative or merely a biomarker for RGC loss in glaucoma is unknown. Here we analyzed the role of NRF2, a master regulator of the antioxidant response, in Hhcy-induced RGC death in vivo and in vitro. By crossing Nrf2

Indexed as

AnimalsBiomarkersCell CountCoculture TechniquesDisease Models, AnimalElectroretinographyEpendymoglial CellsGlycolysisHyperhomocysteinemiaIntraocular PressureMiceMice, KnockoutNF-E2-Related Factor 2RetinaRetinal Ganglion CellsBiomarkersNF-E2-Related Factor 2Cystathionine β-synthaseGanglion cellsGlaucomaHomocysteineHyperhomocysteinemiaMethylene tetrahydrofolate reductaseMouseNRF2Retina

Identifiers

PMID31026769
PMCPMC6482349
OpenAlexW2936033672

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.